# A Study to Look at How a Single Oral Dose of Carbon-14-Labelled [14C] BIIB091 Moves Through and is Processed by the Body in Healthy Male Participants

> **NCT06311786** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** [14C]-BIIB091

## Key facts

- **NCT ID:** NCT06311786
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-08
- **Primary completion:** 2024-05-11
- **Final completion:** 2024-05-11
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06311786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06311786, "A Study to Look at How a Single Oral Dose of Carbon-14-Labelled [14C] BIIB091 Moves Through and is Processed by the Body in Healthy Male Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06311786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*